Gabriela Ecco is an accomplished professional with extensive experience in the biotechnology and therapeutics sectors. Currently serving as a Board Observer at Notify Therapeutics and various organizations including AIRNA and Osasuna Therapeutics, Gabriela has held multiple roles at +ND Capital, progressing from Innovation Fellow to Senior Associate. Previous tenure at SOPHiA GENETICS involved leading R&D projects for next generation sequencing products related to precision medicine and oncology. Gabriela's academic credentials include a PhD in Biotechnology and Bioengineering from EPFL, complemented by a CAS in Management of Biotech, Medtech & Pharma Ventures, and a BSc in Biology from Universidade Federal de Santa Catarina.